André C Carpentier, Denis P Blondin, François Haman, Denis Richard
{"title":"Brown Adipose Tissue-A Translational Perspective.","authors":"André C Carpentier, Denis P Blondin, François Haman, Denis Richard","doi":"10.1210/endrev/bnac015","DOIUrl":null,"url":null,"abstract":"<p><p>Brown adipose tissue (BAT) displays the unique capacity to generate heat through uncoupled oxidative phosphorylation that makes it a very attractive therapeutic target for cardiometabolic diseases. Here, we review BAT cellular metabolism, its regulation by the central nervous and endocrine systems and circulating metabolites, the plausible roles of this tissue in human thermoregulation, energy balance, and cardiometabolic disorders, and the current knowledge on its pharmacological stimulation in humans. The current definition and measurement of BAT in human studies relies almost exclusively on BAT glucose uptake from positron emission tomography with 18F-fluorodeoxiglucose, which can be dissociated from BAT thermogenic activity, as for example in insulin-resistant states. The most important energy substrate for BAT thermogenesis is its intracellular fatty acid content mobilized from sympathetic stimulation of intracellular triglyceride lipolysis. This lipolytic BAT response is intertwined with that of white adipose (WAT) and other metabolic tissues, and cannot be independently stimulated with the drugs tested thus far. BAT is an interesting and biologically plausible target that has yet to be fully and selectively activated to increase the body's thermogenic response and shift energy balance. The field of human BAT research is in need of methods able to directly, specifically, and reliably measure BAT thermogenic capacity while also tracking the related thermogenic responses in WAT and other tissues. Until this is achieved, uncertainty will remain about the role played by this fascinating tissue in human cardiometabolic diseases.</p>","PeriodicalId":11544,"journal":{"name":"Endocrine reviews","volume":"44 2","pages":"143-192"},"PeriodicalIF":22.0000,"publicationDate":"2023-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985413/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/endrev/bnac015","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Brown adipose tissue (BAT) displays the unique capacity to generate heat through uncoupled oxidative phosphorylation that makes it a very attractive therapeutic target for cardiometabolic diseases. Here, we review BAT cellular metabolism, its regulation by the central nervous and endocrine systems and circulating metabolites, the plausible roles of this tissue in human thermoregulation, energy balance, and cardiometabolic disorders, and the current knowledge on its pharmacological stimulation in humans. The current definition and measurement of BAT in human studies relies almost exclusively on BAT glucose uptake from positron emission tomography with 18F-fluorodeoxiglucose, which can be dissociated from BAT thermogenic activity, as for example in insulin-resistant states. The most important energy substrate for BAT thermogenesis is its intracellular fatty acid content mobilized from sympathetic stimulation of intracellular triglyceride lipolysis. This lipolytic BAT response is intertwined with that of white adipose (WAT) and other metabolic tissues, and cannot be independently stimulated with the drugs tested thus far. BAT is an interesting and biologically plausible target that has yet to be fully and selectively activated to increase the body's thermogenic response and shift energy balance. The field of human BAT research is in need of methods able to directly, specifically, and reliably measure BAT thermogenic capacity while also tracking the related thermogenic responses in WAT and other tissues. Until this is achieved, uncertainty will remain about the role played by this fascinating tissue in human cardiometabolic diseases.
棕色脂肪组织(BAT)具有通过非偶联氧化磷酸化产生热量的独特能力,这使其成为治疗心脏代谢疾病的一个极具吸引力的靶点。在此,我们回顾了黑脂肪组织的细胞代谢、中枢神经和内分泌系统对其的调节以及循环代谢产物,该组织在人体体温调节、能量平衡和心脏代谢疾病中的合理作用,以及目前对其进行药理刺激的知识。目前人体研究中对 BAT 的定义和测量几乎完全依赖于 18F- 氟脱氧葡萄糖正电子发射断层扫描对 BAT 葡萄糖的摄取,这可能与 BAT 的生热活动相分离,例如在胰岛素抵抗状态下。BAT 产热最重要的能量基质是交感神经刺激细胞内甘油三酯脂肪分解所动员的细胞内脂肪酸含量。BAT 的这种脂肪分解反应与白色脂肪(WAT)和其他代谢组织的反应交织在一起,迄今为止所测试的药物无法单独刺激 BAT。BAT 是一个有趣的、生物学上合理的靶点,但尚未被完全和有选择性地激活,以增加机体的生热反应和改变能量平衡。人体 BAT 研究领域需要能够直接、具体、可靠地测量 BAT 生热能力的方法,同时还要跟踪 WAT 和其他组织的相关生热反应。在实现这一目标之前,这一神奇组织在人类心脏代谢疾病中所扮演的角色仍将存在不确定性。
期刊介绍:
Endocrine Reviews, published bimonthly, features concise timely reviews updating key mechanistic and clinical concepts, alongside comprehensive, authoritative articles covering both experimental and clinical endocrinology themes. The journal considers topics informing clinical practice based on emerging and established evidence from clinical research. It also reviews advances in endocrine science stemming from studies in cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology.